Gynecologic Medicine Service

People

  1. Green
    Green
  2. Tew
    Tew
  3. Makker
    Makker
  4. Cohen
    Cohen
  5. Kyi
    Kyi
  6. Konner
    Konner
  7. Sabbatini
    Sabbatini
  8. Liu
    Liu
  9. Guo
    Guo
  10. O'Cearbhaill
    O'Cearbhaill
  11. Aghajanian
    Aghajanian
  12. Lichtman
    Lichtman
  13. Hensley
    Hensley
  14. Grisham
    Grisham
  15. Troso-Sandoval
    Troso-Sandoval

Description

Publications

  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (158)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (70)
  6. Cancer Research (55)
  7. Cancer (39)
  8. The Oncology Report (38)
  9. Journal for ImmunoTherapy of Cancer (34)
  10. Journal of Geriatric Oncology (33)

Publishers

  1. Elsevier Inc. (544)
  2. American Society of Clinical Oncology (493)
  3. Lippincott Williams & Wilkins (185)
  4. Oxford University Press (125)
  5. American Association for Cancer Research (124)
  6. Nature Publishing Group (83)
  7. Wiley Blackwell (58)
  8. Springer (55)
  9. American Association for Cancer Research (48)
  10. Biomed Central Ltd (40)

Belongs to

Types of Work

Recent Works

  1. Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  2. A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  3. ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Journal Article

    Liu, J. F.; Colombo, N.; Oza, A. M.; Frenel, J. S.; Corr, B. R.; Rubinstein, M. M.; Nevadunsky, N. S.; Lheureux, S.; Gaba, L.; González Cortijo, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save